active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/dGFrZWRhLmNvbQ/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/dGFrZWRhLmNvbQ/images/2025-04-04_logo.svg
cik: 0001395064
composite_figi: BBG000LF8708
currency_name: usd
description: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with
    revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic
    areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived
    therapies, which account for more than 80% of revenue. Its geographic footprint
    is well diversified, with over 50% derived from the US, 20% from Japan, 20% from
    Europe and Canada.
homepage_url: https://www.takeda.com
list_date: '2008-03-07'
locale: us
market: stocks
market_cap: 46646906534.619995
name: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing
    1/2 of a share of Common Stock)
primary_exchange: XNYS
round_lot: 100
share_class_figi: BBG001T8N8N0
share_class_shares_outstanding: 3181925218
ticker: TAK
ticker_root: TAK
total_employees: 47455
type: ADRC
weighted_shares_outstanding: 3158219806
